Given that the above results showed that AKT and Wnt signaling were enriched in pancreatic cancer patients with high LRRFIP1 expression (Fig. 5B, D), and the roles of AKT and Wnt signalings in cancer progression are well established [25, 26]. The gene discussed is AKT1; the disease is pancreatic neoplasm.